Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

36.85
Delayed Data
As of Jul 27
 +0.02 / +0.05%
Today’s Change
28.25
Today|||52-Week Range
37.19
+14.16%
Year-to-Date
5 Incredibly Cheap Big Pharma Stocks
Jul 25 / MotleyFool.com - Paid Partner Content
Pharma Industry Outlook: Fundamentals Remain Strong
Jul 22 / Zacks.com - Paid Partner Content
Zacks Industry Outlook Highlights: Bristol-Myers, Pfizer, Sanofi, Amgen and Biogen
Jul 25 / Zacks.com - Paid Partner Content
Biogen Should Either a Buyer or a Seller Be
Jul 22 / TheStreet.com - Paid Partner Content
Dividend Investors Should Research These 10 Stocks - July
Jul 25 / GuruFocus News - Paid Partner Content
Can You Guess Which Pharma Giant Spends $1 Billion-Plus a Year On Direct-To-Consumer ...
Jul 22 / MotleyFool.com - Paid Partner Content
Bloodlines: Rivals look to create 'off-the-shelf' treatment
Jul 24 / FT.com - Paid Partner Content
Will Pfizer Book Another Healthy Quarter?
Jul 22 / TheStreet.com - Paid Partner Content
3 Important Takeaways From Johnson & Johnson's Second-Quarter Earnings
Jul 24 / MotleyFool.com - Paid Partner Content
Benzinga's M&A Chatter for Thursday July 21, 2016:
Jul 21 / Benzinga - Paid Partner Content

Today’s Trading

Previous close36.83
Today’s open36.75
Day’s range36.65 - 36.92
Volume15,064,000
Average volume (3 months)33,754,161
Market cap$223.4B
Dividend yield3.26%
Data as of 4:00pm ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)-21.24%
Earnings growth (this year)+11.39%
Earnings growth (next 5 years)+6.80%
Revenue growth (last year)-1.52%
P/E ratio30.2
Price/Sales4.13
Price/Book3.52

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.13-0.16%
AGNPRAAllergan plc+32.76+3.71%
MRKMerck+0.24+0.41%
BMYBristol-Myers Squibb+1.41+1.88%
Data as of 4:02pm ET, 07/27/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$0.61
Annual revenue (last year)$48.9B
Annual profit (last year)$7.0B
Net profit margin14.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs